📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

A GLP1 receptor agonist diabetes drug ameliorates neurodegeneration in a mouse model of infantile neurometabolic disease. (2022)

First Author: Poupon-Bejuit L
Attributed to:  MICA: Towards clinical trial readiness of gene therapy for Niemann-Pick disease type c funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-022-17338-1

PubMed Identifier: 35970890

Publication URI: http://europepmc.org/abstract/MED/35970890

Type: Journal Article/Review

Volume: 12

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322